They discovered that 18βGA suppresses invasion and metastasis in gastric cancer cells (SGC-7901 cells) through the ROS/protein kinase C-alpha (PKCα)/ERK signaling pathway, suggesting that it could be used as a chemopreventive drug to prevent gastric cancer metastases [41]. Here, PRKCA is linked to gastric cancer.